BRPI0409995A - composto, e, agente anti-leishmánia - Google Patents

composto, e, agente anti-leishmánia

Info

Publication number
BRPI0409995A
BRPI0409995A BRPI0409995-8A BRPI0409995A BRPI0409995A BR PI0409995 A BRPI0409995 A BR PI0409995A BR PI0409995 A BRPI0409995 A BR PI0409995A BR PI0409995 A BRPI0409995 A BR PI0409995A
Authority
BR
Brazil
Prior art keywords
compound
agent
specific
heterocycle
membered
Prior art date
Application number
BRPI0409995-8A
Other languages
English (en)
Inventor
Masataka Ihara
Kiyosei Takasu
Hiroki Terauchi
Setsuko Sekita
Marii Takahashi
Original Assignee
Japan Science & Tech Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Science & Tech Agency filed Critical Japan Science & Tech Agency
Publication of BRPI0409995A publication Critical patent/BRPI0409995A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"AGENTE ANTI-LEISHMáNIA". A presente invenção é para fornecer um novo agente antileishmânia com menos efeitos colaterais, tendo um efeito de inibir a proliferação de célula alto para o protozoário Leishâmia e também fácil de fabricar a um custo baixo. Um composto em que um heterociclo com um sistema conjugado e um átomo de nitrogênio e um heterociclo com um átomo de nitrogênio e um átomo de enxofre são ligados por uma cadeia carbónica com um grupo etileno, isto é um composto em que um anel heterocíclico de 5 a 8 membros específico e um heterociclo de 5 a 8 membros específico tendo um sistema conjugado são ligados por intermédio de um grupo vinileno, mais particularmente um composto corante de rodacianina específico é usado como um ingrediente ativo do agente anti-leishmânia.
BRPI0409995-8A 2003-05-06 2004-04-30 composto, e, agente anti-leishmánia BRPI0409995A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003128454A JP2004331545A (ja) 2003-05-06 2003-05-06 抗リーシュマニア剤
PCT/JP2004/006315 WO2004108695A1 (ja) 2003-05-06 2004-04-30 抗リーシュマニア剤

Publications (1)

Publication Number Publication Date
BRPI0409995A true BRPI0409995A (pt) 2006-05-09

Family

ID=33504600

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0409995-8A BRPI0409995A (pt) 2003-05-06 2004-04-30 composto, e, agente anti-leishmánia

Country Status (5)

Country Link
US (1) US20060252800A1 (pt)
EP (1) EP1623981A4 (pt)
JP (1) JP2004331545A (pt)
BR (1) BRPI0409995A (pt)
WO (1) WO2004108695A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4553354B2 (ja) * 2004-10-04 2010-09-29 正隆 井原 抗トリパノソーマ剤
JP4553355B2 (ja) 2004-10-04 2010-09-29 富士フイルム株式会社 トリパノソーマ原虫寄生感染症の予防又は治療用医薬組成物
JPWO2006137258A1 (ja) * 2005-06-24 2009-01-08 独立行政法人科学技術振興機構 アザロダシアニン化合物を有効成分として含有する医薬組成物
US8038214B2 (en) 2009-02-11 2011-10-18 Cosco Management, Inc. Harness system for juvenile vehicle seat
US8471036B2 (en) 2009-10-13 2013-06-25 Fujifilm Corporation Rhodacyanine derivative and pharmaceutical composition for treating leishmaniasis
WO2012053232A1 (ja) 2010-10-19 2012-04-26 学校法人青山学院 抗リーシュマニア化合物及び抗リーシュマニア薬
JP4762381B1 (ja) 2010-10-19 2011-08-31 学校法人青山学院 抗リーシュマニア化合物及び抗リーシュマニア薬
US9642843B2 (en) 2013-02-27 2017-05-09 The Regents Of The University Of Michigan Pharmaceutical compounds and use of same in cancer and tauopathies

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO923126L (no) * 1991-08-13 1993-02-15 Fuji Photo Film Co Ltd Preparat og metode for behandling av canser
AU678116B2 (en) * 1994-07-21 1997-05-15 Fuji Photo Film Co., Ltd. Water-soluble methine compound and pharmaceutical composition for treatment of cancer comprising the same
JPH0859467A (ja) * 1994-08-18 1996-03-05 Fuji Photo Film Co Ltd 皮膚疾患治療薬
JP4090133B2 (ja) * 1998-12-28 2008-05-28 富士フイルム株式会社 抗マラリア剤
JP2001354564A (ja) * 2000-06-14 2001-12-25 Chugai Bunshi Igaku Kenkyusho:Kk カチオン性ローダシアニン系色素誘導体を有効成分とする、ｍｏｔ−２蛋白質とｐ５３蛋白質の相互作用阻害剤
JP2003034640A (ja) * 2001-07-19 2003-02-07 Japan Science & Technology Corp 四環性複素化合物を含有する抗マラリア剤
JP2003034642A (ja) * 2001-07-19 2003-02-07 Japan Science & Technology Corp ロダシアニン色素化合物を含有する抗マラリア剤
JP2003034641A (ja) * 2001-07-19 2003-02-07 Japan Science & Technology Corp ロダシアニン系色素化合物を含有する抗マラリア剤

Also Published As

Publication number Publication date
EP1623981A1 (en) 2006-02-08
WO2004108695A1 (ja) 2004-12-16
US20060252800A1 (en) 2006-11-09
JP2004331545A (ja) 2004-11-25
EP1623981A4 (en) 2008-07-23

Similar Documents

Publication Publication Date Title
ES2188016T3 (es) Derivaqdo de benzamidoxima, productos intermedios y procedimiento para su obtencion y su empleo como fungicidas.
EA200400480A1 (ru) N-замещённые производные пирролидина в качестве ингибиторов дипептидилпептидазы
EA200500018A1 (ru) Бензконденсированные гетероариламидные производные тиенопиридинов, применяемые в качестве терапевтических агентов, фармацевтические композиции, включающие их, и способы их применения
AR008496A1 (es) Nuevos oxadiazoles, procedimiento para su preparacion asi como su empleo como medicamentos.
BRPI0510059A (pt) inibidores da transcriptase reversa não-nucleosìdica
EA200401609A1 (ru) Лекарственное средство для лечения диабета
SE0300956L (sv) Stabilisatorblandningar
BR0312999A (pt) Compostos, composições farmacêticas, método para aumentar a cognição, de tratamento, de inibição da atividade de enzima pde4 em um paciente
BR0307575A (pt) Derivados de sulfonila como inibidores de histona desacetilase
PA8544901A1 (es) Derivados de oxazol
BR0206433A (pt) Composto, composição farmacêutica, processo para a prepapação de um composto, e, uso de um composto
AR068538A1 (es) Compuesto heterociclico de 5 miembros con actividad supresora de la secrecion de acido
AR047531A1 (es) Derivados 1h-tieno(2,3-c)pirazol utiles como inhibidores de quinasa
NZ330973A (en) Azolobenzazepine derivatives as neurologically active agents
KR920014810A (ko) 항균제
BRPI0409995A (pt) composto, e, agente anti-leishmánia
MX9202282A (es) Nuevos derivados de 3-amino piridazinas, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
UY29221A1 (es) Derivados de octahidropirrolo(3,4-c)pirrol
PT1202959E (pt) Aminobenzofenonas como inibidores de il-1-beta e tnf-alfa
BR0312921A (pt) Composição compreendendo inibidor de reductase hmg-coa
CO5080727A1 (es) Ligandos azabiciclicos de receptores 5 ht1
CR7249A (es) Derivados de diamina, proceso para producir los derivados de diamina, y funguicidas que contienen los derivados de diamina como ingrediente activo
BR9916807A (pt) Antagonistas de 5ht1 para terapia antidepressiva
UY30552A1 (es) Combinaciones farmacologiicas en base a derivados sustituidos de la n-(5-{2-[1,1-dimetil-propilamino]-1-hidroxi-metil}-2-hidroxi-fenil)-metansulfonamida y aplicaciones
BRPI0510625A (pt) tienopiridinas como inibidores de ikk

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.